Viewing Study NCT01303705


Ignite Creation Date: 2025-12-25 @ 3:22 AM
Ignite Modification Date: 2026-02-25 @ 8:59 PM
Study NCT ID: NCT01303705
Status: COMPLETED
Last Update Posted: 2018-08-29
First Post: 2010-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Sponsor: Providence Health & Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module